Jens Hoffmann

ORCID: 0000-0003-3880-1658 · 2 papers in corpus
review 2008
Expert opinion on investigational drugs ·doi:10.1517/13543784.17.4.469

BACKGROUND: Clinical evidence has shown that conditions such as uterine fibroids, endometriosis and breast cancer are progesterone-dependent diseases. Therefore, progesterone receptor (PR) antagonists and selective PR modulators (SPRMs) are…

other 2000
Journal of medicinal chemistry ·doi:10.1021/jm001000c

Herein we describe the chemical synthesis and pharmacological characterization of a novel, highly potent progesterone receptor (PR) antagonist, ZK 230211. The introduction of a 17alpha-pentafluorethyl side chain in the D-ring of the steroid…